Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus

    Abstract Full Text
    online first
    JAMA. 2024; 10.1001/jama.2024.5859

    This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.

  • Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members

    Abstract Full Text
    open access is active quiz
    ÁñÁ«ÊÓƵ Netw Open. 2022; 5(8):e2227348. 10.1001/jamanetworkopen.2022.27348

    This cohort study assesses SARS-CoV-2 incidence, clinical and virological features, and symptoms among children aged 0 to 4 years compared with older children and adults.

  • Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York

    Abstract Full Text
    free access
    JAMA Pediatr. 2021; 176(1):59-67. 10.1001/jamapediatrics.2021.4217

    This cohort study of households in selected Utah counties and New York City, New York, compares incidence rates and clinical characteristics of SARS-CoV-2 infection among adults and children and prospectively assesses infection risks.